Log in  First Connection?

VaccinesArchives

Modeling the impact of vaccine dose prioritization strategies during the 2022 mpox outbreak
Vaccines
 1 min.

 Published on 07/05/2026 |  Original article (Full-text)  | Patrick A Clay et al. | American Journal of Epidemiology. Volume 195(4).

Early in the 2022 mpox outbreak, the US recommendation was to administer two doses of the JYNNEOS vaccine 4 weeks apart. However, because of limited vaccine supply, New York City (NYC) prioritized single dose vaccination. We estimated mpox cases averted by this strategy compared to strategies that prioritized...

Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunities
Vaccines
 1 min.

 Published on 30/04/2026 |  Original article (Full-text)  | Maria Buti et al. | Expert Review of Vaccines 2025; 24(1): 373-83

Hepatitis B and hepatitis A are vaccine-preventable infections of global concern. Hepatitis B virus (HBV) and hepatitis A virus (HAV) vaccines available in Europe are underutilized in some age groups. While most European countries implemented childhood HBV universal routine vaccination (URV), vaccination...

Can vaccine-preventable disease resurgence be anticipated? Leading indicators and tipping points
Vaccines
 1 min.

 Published on 23/04/2026 |  Original article (Full-text)  | John M. Drake et al. | Future Microbiology 2026; 21(3): 321-7

Vaccination programs have averted millions of childhood deaths, yet vaccine-preventable diseases (VPDs) continue to resurge as coverage declines and pathogen evolution undermines previously successful vaccines. Anticipating resurgence is a public health priority. We review theoretical and empirical advances...

Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China
Vaccines
 1 min.

 Published on 16/04/2026 |  Original article (Full-text)  | Wenzhou Yu et al. | International journal of epidemiology. Volume 45(2).

China reduced hepatitis B virus (HBV) infection by 90% among children under 5 years old with safe and effective hepatitis B vaccines (HepB). In December 2013, this success was threatened by widespread media reports of infant deaths following HepB administration. Seventeen deaths and one case of anaphylactic...

COVID-19 burden in the paediatric population in Latin America during vaccine rollout: a real-world study using national surveillance data
Vaccines
 6 min.

 Published on 09/04/2026 |  Original article (Full-text)  | Spinardi Júlia et al. | BMC Infectious Diseases 2026; 26(1): 422

Coronavirus disease 2019 (COVID-19) has impacted the health and well-being of children and adolescents worldwide [1]. Although COVID-19 generally has a milder presentation in the paediatric population, severe outcomes, including hospitalisation and death, can still occur, especially among those with...